Stock Markets April 13, 2026 07:05 AM

Northland Lifts Intel Target to Street-High $92, Citing Increased Fab Value

Analyst bumps PP&E multiple and highlights growing demand for leading-edge logic capacity as Intel tightens control of key fabs

By Ajmal Hussain INTC
Northland Lifts Intel Target to Street-High $92, Citing Increased Fab Value
INTC

Northland Capital Markets raised its price target on Intel to $92, driven by a revised valuation of the company’s manufacturing assets and the strategic significance of recent partnerships and capital transactions. The firm increased the multiple applied to Intel’s property, plant and equipment from 1x to 3x in its sum-of-the-parts valuation, and pointed to deals with major tech and government players alongside expanding advanced-node capacity as justification.

Key Points

  • Northland increased the multiple on Intel’s property, plant and equipment from 1x to 3x, driving a $92 price target.
  • Intel has deals with the U.S. government, Nvidia, Tesla and Google and has attracted about $17.9 billion in investments and asset monetizations.
  • Intel now runs three fabs capable of 3nm and below and repurchased the remaining 49% of Fab 34 from Apollo for $14.2 billion.

Northland Capital Markets has raised its price target on Intel Corporation to $92, putting it at the top of Street estimates, after re-evaluating the worth of the chipmaker’s manufacturing footprint and related strategic arrangements.

In a sum-of-the-parts analysis, Northland increased the multiple on Intel’s property, plant and equipment from 1x balance-sheet value to 3x, reflecting what the firm sees as higher intrinsic value in the company’s factories and long-term capacity. That adjustment was central to the new price target.

The analyst note highlights a series of commercial and governmental agreements that underscore Intel’s role among the remaining group of leading-edge logic foundries. Intel has secured arrangements with the U.S. government, Nvidia, Tesla and Google, underscoring its position as one of three leading logic chipmakers still operating at the most advanced nodes.

On the technology front, the company began shipping products based on its 18a process node in January 2026, meeting a production roadmap goal to develop five process nodes over four years that had been set out by its former chief executive in 2021. Northland also cited recent capital inflows to the business, noting the current CEO has drawn roughly $17.9 billion into Intel through investments from Nvidia, SoftBank, the U.S. government and the sale of 51% of Altera.

Strategic asset moves feature prominently in Northland’s view. Intel agreed to repurchase a 49% interest in Fab 34 from Apollo for $14.2 billion, returning full ownership of that facility to the company. Intel now operates three fabs capable of manufacturing at 3nm and below, a capacity set the firm apart in Northland’s assessment.

Northland expects 3nm capacity to become tighter in 2027, which it says would increase the value of facilities capable of producing at that node. The analyst firm emphasized a scarcity of leading-edge logic capacity and stated it is unlikely another company will field a competitive 3nm process within the next decade. The note also raised geopolitical considerations in its valuation, pointing to Taiwan’s potential reunification with China as a factor that could constrain access to TSMC’s capacity.

The firm reflected on Intel’s trajectory over recent leadership changes. When the previous CEO assumed control, Intel’s most advanced product was at 10nm while TSMC was shipping 5nm chips, a two-node gap. Northland acknowledged it had been early in upgrading its view of Intel previously but said the company has made meaningful progress under the last two CEOs in addressing its operational challenges.


Clear summary: Northland lifted its price target on Intel to $92 chiefly by applying a higher multiple to Intel’s balance-sheet property, plant and equipment and by factoring in recent commercial deals, capital investments, and tightened near-term 3nm capacity.

  • Key points:
  • Northland raised Intel’s PP&E multiple from 1x to 3x in a sum-of-the-parts valuation; this change drove the new $92 target.
  • Intel has deals with the U.S. government, Nvidia, Tesla and Google and has secured roughly $17.9 billion in inflows through investments and asset sales.
  • Intel operates three fabs capable of 3nm and below and repurchased a 49% stake in Fab 34 from Apollo for $14.2 billion, restoring full ownership.
  • Risks/uncertainties:
  • Leading-edge logic capacity is scarce; Northland expects 3nm capacity to tighten in 2027, which could stress supply in semiconductors and related markets.
  • Geopolitical risk: Northland flagged Taiwan’s potential reunification with China as a factor that could limit access to TSMC capacity, introducing uncertainty for global supply chains.
  • Technology timing: Northland stated it is unlikely another company will have a competitive 3nm process within the next decade, but that assessment itself is an uncertainty impacting competitive dynamics in semiconductor manufacturing.

Risks

  • Tightening 3nm capacity expected in 2027 could create supply constraints for advanced semiconductors, affecting the semiconductor sector and end markets reliant on cutting-edge chips.
  • Geopolitical uncertainty tied to Taiwan’s potential reunification with China could limit access to TSMC capacity and disrupt global semiconductor supply chains.
  • The projection that no competitor will field a competitive 3nm process over the next decade introduces execution risk if that expectation changes, impacting competitive dynamics in chip manufacturing.

More from Stock Markets

National Healthcare Properties Targets $1.1 Billion Valuation in U.S. IPO Apr 13, 2026 JPMorgan Urges Investors to Buy Pullbacks, Sees Setup for Another V-Shaped Recovery Apr 13, 2026 Argus trims Ukraine 2026 wheat estimate; output still highest since 2022 invasion Apr 13, 2026 Revolution Medicines Shares Soar After Phase 3 Pancreatic Cancer Results Apr 13, 2026 Allogene Shares Jump After Interim ALPHA3 Results Show Large MRD Benefit Apr 13, 2026